Global Lisinopril Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Publisher Name :
Date: 05-May-2022
No. of pages: 128

The Lisinopril market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lisinopril market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Lisinopril global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2.5mg segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Lisinopril include Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, and Lek Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Lisinopril market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- 2.5mg

- 5mg

- 10mg

- 20mg

- 30mg

- 40mg

Market segment by Application can be divided into

- Hospital

- Drug Store

The key market players for global Lisinopril market are listed below:

- Actavis Elizabeth

- Apotex

- Aurobindo Pharma

- Ivax Pharmaceuticals

- Lek Pharmaceuticals

- Lupin

- Mylan Pharmaceuticals

- Ranbaxy Pharmaceuticals

- Novartis

- Teva Pharmaceuticals

- Vintage Pharmaceuticals

- Watson Laboratories

- West Ward Pharmaceutical

- Wockhardt

- Merck Research Laboratories

- Astrazeneca

- Alvogen

- Hikma

- Prinston

- Accord Hlthcare

- CASI Pharms

- Invagen Pharms

- SUN Pharm

Market segment by region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Lisinopril product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Lisinopril, with price, sales, revenue and global market share of Lisinopril from 2019 to 2022.

Chapter 3, the Lisinopril competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Lisinopril breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lisinopril market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Lisinopril.

Chapter 13, 14, and 15, to describe Lisinopril sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Lisinopril Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
1.1 Lisinopril Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lisinopril Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Lisinopril Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Lisinopril Market Size & Forecast
1.4.1 Global Lisinopril Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lisinopril Sales in Volume (2017-2028)
1.4.3 Global Lisinopril Price (2017-2028)
1.5 Global Lisinopril Production Capacity Analysis
1.5.1 Global Lisinopril Total Production Capacity (2017-2028)
1.5.2 Global Lisinopril Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lisinopril Market Drivers
1.6.2 Lisinopril Market Restraints
1.6.3 Lisinopril Trends Analysis
2 Manufacturers Profiles
2.1 Actavis Elizabeth
2.1.1 Actavis Elizabeth Details
2.1.2 Actavis Elizabeth Major Business
2.1.3 Actavis Elizabeth Lisinopril Product and Services
2.1.4 Actavis Elizabeth Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Apotex
2.2.1 Apotex Details
2.2.2 Apotex Major Business
2.2.3 Apotex Lisinopril Product and Services
2.2.4 Apotex Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Aurobindo Pharma
2.3.1 Aurobindo Pharma Details
2.3.2 Aurobindo Pharma Major Business
2.3.3 Aurobindo Pharma Lisinopril Product and Services
2.3.4 Aurobindo Pharma Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ivax Pharmaceuticals
2.4.1 Ivax Pharmaceuticals Details
2.4.2 Ivax Pharmaceuticals Major Business
2.4.3 Ivax Pharmaceuticals Lisinopril Product and Services
2.4.4 Ivax Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lek Pharmaceuticals
2.5.1 Lek Pharmaceuticals Details
2.5.2 Lek Pharmaceuticals Major Business
2.5.3 Lek Pharmaceuticals Lisinopril Product and Services
2.5.4 Lek Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Lisinopril Product and Services
2.6.4 Lupin Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mylan Pharmaceuticals
2.7.1 Mylan Pharmaceuticals Details
2.7.2 Mylan Pharmaceuticals Major Business
2.7.3 Mylan Pharmaceuticals Lisinopril Product and Services
2.7.4 Mylan Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ranbaxy Pharmaceuticals
2.8.1 Ranbaxy Pharmaceuticals Details
2.8.2 Ranbaxy Pharmaceuticals Major Business
2.8.3 Ranbaxy Pharmaceuticals Lisinopril Product and Services
2.8.4 Ranbaxy Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Lisinopril Product and Services
2.9.4 Novartis Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceuticals
2.10.1 Teva Pharmaceuticals Details
2.10.2 Teva Pharmaceuticals Major Business
2.10.3 Teva Pharmaceuticals Lisinopril Product and Services
2.10.4 Teva Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Vintage Pharmaceuticals
2.11.1 Vintage Pharmaceuticals Details
2.11.2 Vintage Pharmaceuticals Major Business
2.11.3 Vintage Pharmaceuticals Lisinopril Product and Services
2.11.4 Vintage Pharmaceuticals Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Watson Laboratories
2.12.1 Watson Laboratories Details
2.12.2 Watson Laboratories Major Business
2.12.3 Watson Laboratories Lisinopril Product and Services
2.12.4 Watson Laboratories Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 West Ward Pharmaceutical
2.13.1 West Ward Pharmaceutical Details
2.13.2 West Ward Pharmaceutical Major Business
2.13.3 West Ward Pharmaceutical Lisinopril Product and Services
2.13.4 West Ward Pharmaceutical Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Wockhardt
2.14.1 Wockhardt Details
2.14.2 Wockhardt Major Business
2.14.3 Wockhardt Lisinopril Product and Services
2.14.4 Wockhardt Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Merck Research Laboratories
2.15.1 Merck Research Laboratories Details
2.15.2 Merck Research Laboratories Major Business
2.15.3 Merck Research Laboratories Lisinopril Product and Services
2.15.4 Merck Research Laboratories Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Astrazeneca
2.16.1 Astrazeneca Details
2.16.2 Astrazeneca Major Business
2.16.3 Astrazeneca Lisinopril Product and Services
2.16.4 Astrazeneca Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Alvogen
2.17.1 Alvogen Details
2.17.2 Alvogen Major Business
2.17.3 Alvogen Lisinopril Product and Services
2.17.4 Alvogen Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Hikma
2.18.1 Hikma Details
2.18.2 Hikma Major Business
2.18.3 Hikma Lisinopril Product and Services
2.18.4 Hikma Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Prinston
2.19.1 Prinston Details
2.19.2 Prinston Major Business
2.19.3 Prinston Lisinopril Product and Services
2.19.4 Prinston Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Accord Hlthcare
2.20.1 Accord Hlthcare Details
2.20.2 Accord Hlthcare Major Business
2.20.3 Accord Hlthcare Lisinopril Product and Services
2.20.4 Accord Hlthcare Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 CASI Pharms
2.21.1 CASI Pharms Details
2.21.2 CASI Pharms Major Business
2.21.3 CASI Pharms Lisinopril Product and Services
2.21.4 CASI Pharms Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Invagen Pharms
2.22.1 Invagen Pharms Details
2.22.2 Invagen Pharms Major Business
2.22.3 Invagen Pharms Lisinopril Product and Services
2.22.4 Invagen Pharms Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 SUN Pharm
2.23.1 SUN Pharm Details
2.23.2 SUN Pharm Major Business
2.23.3 SUN Pharm Lisinopril Product and Services
2.23.4 SUN Pharm Lisinopril Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lisinopril Breakdown Data by Manufacturer
3.1 Global Lisinopril Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lisinopril Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lisinopril
3.4 Market Concentration Rate
3.4.1 Top 3 Lisinopril Manufacturer Market Share in 2021
3.4.2 Top 6 Lisinopril Manufacturer Market Share in 2021
3.5 Global Lisinopril Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lisinopril Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lisinopril Market Size by Region
4.1.1 Global Lisinopril Sales in Volume by Region (2017-2028)
4.1.2 Global Lisinopril Revenue by Region (2017-2028)
4.2 North America Lisinopril Revenue (2017-2028)
4.3 Europe Lisinopril Revenue (2017-2028)
4.4 Asia-Pacific Lisinopril Revenue (2017-2028)
4.5 South America Lisinopril Revenue (2017-2028)
4.6 Middle East and Africa Lisinopril Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lisinopril Sales in Volume by Type (2017-2028)
5.2 Global Lisinopril Revenue by Type (2017-2028)
5.3 Global Lisinopril Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lisinopril Sales in Volume by Application (2017-2028)
6.2 Global Lisinopril Revenue by Application (2017-2028)
6.3 Global Lisinopril Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lisinopril Sales by Type (2017-2028)
7.2 North America Lisinopril Sales by Application (2017-2028)
7.3 North America Lisinopril Market Size by Country
7.3.1 North America Lisinopril Sales in Volume by Country (2017-2028)
7.3.2 North America Lisinopril Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lisinopril Sales by Type (2017-2028)
8.2 Europe Lisinopril Sales by Application (2017-2028)
8.3 Europe Lisinopril Market Size by Country
8.3.1 Europe Lisinopril Sales in Volume by Country (2017-2028)
8.3.2 Europe Lisinopril Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lisinopril Sales by Type (2017-2028)
9.2 Asia-Pacific Lisinopril Sales by Application (2017-2028)
9.3 Asia-Pacific Lisinopril Market Size by Region
9.3.1 Asia-Pacific Lisinopril Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lisinopril Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lisinopril Sales by Type (2017-2028)
10.2 South America Lisinopril Sales by Application (2017-2028)
10.3 South America Lisinopril Market Size by Country
10.3.1 South America Lisinopril Sales in Volume by Country (2017-2028)
10.3.2 South America Lisinopril Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lisinopril Sales by Type (2017-2028)
11.2 Middle East & Africa Lisinopril Sales by Application (2017-2028)
11.3 Middle East & Africa Lisinopril Market Size by Country
11.3.1 Middle East & Africa Lisinopril Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lisinopril Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lisinopril and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lisinopril
12.3 Lisinopril Production Process
12.4 Lisinopril Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lisinopril Typical Distributors
13.3 Lisinopril Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Lisinopril Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Lisinopril Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Actavis Elizabeth Basic Information, Manufacturing Base and Competitors
Table 4. Actavis Elizabeth Major Business
Table 5. Actavis Elizabeth Lisinopril Product and Services
Table 6. Actavis Elizabeth Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Apotex Basic Information, Manufacturing Base and Competitors
Table 8. Apotex Major Business
Table 9. Apotex Lisinopril Product and Services
Table 10. Apotex Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Aurobindo Pharma Major Business
Table 13. Aurobindo Pharma Lisinopril Product and Services
Table 14. Aurobindo Pharma Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Ivax Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Ivax Pharmaceuticals Major Business
Table 17. Ivax Pharmaceuticals Lisinopril Product and Services
Table 18. Ivax Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Lek Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Lek Pharmaceuticals Major Business
Table 21. Lek Pharmaceuticals Lisinopril Product and Services
Table 22. Lek Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Lupin Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Major Business
Table 25. Lupin Lisinopril Product and Services
Table 26. Lupin Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Mylan Pharmaceuticals Major Business
Table 29. Mylan Pharmaceuticals Lisinopril Product and Services
Table 30. Mylan Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ranbaxy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Ranbaxy Pharmaceuticals Major Business
Table 33. Ranbaxy Pharmaceuticals Lisinopril Product and Services
Table 34. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novartis Basic Information, Manufacturing Base and Competitors
Table 36. Novartis Major Business
Table 37. Novartis Lisinopril Product and Services
Table 38. Novartis Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceuticals Major Business
Table 41. Teva Pharmaceuticals Lisinopril Product and Services
Table 42. Teva Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Vintage Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Vintage Pharmaceuticals Major Business
Table 45. Vintage Pharmaceuticals Lisinopril Product and Services
Table 46. Vintage Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Watson Laboratories Basic Information, Manufacturing Base and Competitors
Table 48. Watson Laboratories Major Business
Table 49. Watson Laboratories Lisinopril Product and Services
Table 50. Watson Laboratories Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. West Ward Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. West Ward Pharmaceutical Major Business
Table 53. West Ward Pharmaceutical Lisinopril Product and Services
Table 54. West Ward Pharmaceutical Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 56. Wockhardt Major Business
Table 57. Wockhardt Lisinopril Product and Services
Table 58. Wockhardt Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Merck Research Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Merck Research Laboratories Major Business
Table 61. Merck Research Laboratories Lisinopril Product and Services
Table 62. Merck Research Laboratories Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 64. Astrazeneca Major Business
Table 65. Astrazeneca Lisinopril Product and Services
Table 66. Astrazeneca Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Alvogen Basic Information, Manufacturing Base and Competitors
Table 68. Alvogen Major Business
Table 69. Alvogen Lisinopril Product and Services
Table 70. Alvogen Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Hikma Basic Information, Manufacturing Base and Competitors
Table 72. Hikma Major Business
Table 73. Hikma Lisinopril Product and Services
Table 74. Hikma Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Prinston Basic Information, Manufacturing Base and Competitors
Table 76. Prinston Major Business
Table 77. Prinston Lisinopril Product and Services
Table 78. Prinston Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Accord Hlthcare Basic Information, Manufacturing Base and Competitors
Table 80. Accord Hlthcare Major Business
Table 81. Accord Hlthcare Lisinopril Product and Services
Table 82. Accord Hlthcare Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. CASI Pharms Basic Information, Manufacturing Base and Competitors
Table 84. CASI Pharms Major Business
Table 85. CASI Pharms Lisinopril Product and Services
Table 86. CASI Pharms Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Invagen Pharms Basic Information, Manufacturing Base and Competitors
Table 88. Invagen Pharms Major Business
Table 89. Invagen Pharms Lisinopril Product and Services
Table 90. Invagen Pharms Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. SUN Pharm Basic Information, Manufacturing Base and Competitors
Table 92. SUN Pharm Major Business
Table 93. SUN Pharm Lisinopril Product and Services
Table 94. SUN Pharm Lisinopril Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Global Lisinopril Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 96. Global Lisinopril Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 97. Market Position of Manufacturers in Lisinopril, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 98. Global Lisinopril Production Capacity by Company, (K Units): 2020 VS 2021
Table 99. Head Office and Lisinopril Production Site of Key Manufacturer
Table 100. Lisinopril New Entrant and Capacity Expansion Plans
Table 101. Lisinopril Mergers & Acquisitions in the Past Five Years
Table 102. Global Lisinopril Sales by Region (2017-2022) & (K Units)
Table 103. Global Lisinopril Sales by Region (2023-2028) & (K Units)
Table 104. Global Lisinopril Revenue by Region (2017-2022) & (USD Million)
Table 105. Global Lisinopril Revenue by Region (2023-2028) & (USD Million)
Table 106. Global Lisinopril Sales by Type (2017-2022) & (K Units)
Table 107. Global Lisinopril Sales by Type (2023-2028) & (K Units)
Table 108. Global Lisinopril Revenue by Type (2017-2022) & (USD Million)
Table 109. Global Lisinopril Revenue by Type (2023-2028) & (USD Million)
Table 110. Global Lisinopril Price by Type (2017-2022) & (US$/Unit)
Table 111. Global Lisinopril Price by Type (2023-2028) & (US$/Unit)
Table 112. Global Lisinopril Sales by Application (2017-2022) & (K Units)
Table 113. Global Lisinopril Sales by Application (2023-2028) & (K Units)
Table 114. Global Lisinopril Revenue by Application (2017-2022) & (USD Million)
Table 115. Global Lisinopril Revenue by Application (2023-2028) & (USD Million)
Table 116. Global Lisinopril Price by Application (2017-2022) & (US$/Unit)
Table 117. Global Lisinopril Price by Application (2023-2028) & (US$/Unit)
Table 118. North America Lisinopril Sales by Country (2017-2022) & (K Units)
Table 119. North America Lisinopril Sales by Country (2023-2028) & (K Units)
Table 120. North America Lisinopril Revenue by Country (2017-2022) & (USD Million)
Table 121. North America Lisinopril Revenue by Country (2023-2028) & (USD Million)
Table 122. North America Lisinopril Sales by Type (2017-2022) & (K Units)
Table 123. North America Lisinopril Sales by Type (2023-2028) & (K Units)
Table 124. North America Lisinopril Sales by Application (2017-2022) & (K Units)
Table 125. North America Lisinopril Sales by Application (2023-2028) & (K Units)
Table 126. Europe Lisinopril Sales by Country (2017-2022) & (K Units)
Table 127. Europe Lisinopril Sales by Country (2023-2028) & (K Units)
Table 128. Europe Lisinopril Revenue by Country (2017-2022) & (USD Million)
Table 129. Europe Lisinopril Revenue by Country (2023-2028) & (USD Million)
Table 130. Europe Lisinopril Sales by Type (2017-2022) & (K Units)
Table 131. Europe Lisinopril Sales by Type (2023-2028) & (K Units)
Table 132. Europe Lisinopril Sales by Application (2017-2022) & (K Units)
Table 133. Europe Lisinopril Sales by Application (2023-2028) & (K Units)
Table 134. Asia-Pacific Lisinopril Sales by Region (2017-2022) & (K Units)
Table 135. Asia-Pacific Lisinopril Sales by Region (2023-2028) & (K Units)
Table 136. Asia-Pacific Lisinopril Revenue by Region (2017-2022) & (USD Million)
Table 137. Asia-Pacific Lisinopril Revenue by Region (2023-2028) & (USD Million)
Table 138. Asia-Pacific Lisinopril Sales by Type (2017-2022) & (K Units)
Table 139. Asia-Pacific Lisinopril Sales by Type (2023-2028) & (K Units)
Table 140. Asia-Pacific Lisinopril Sales by Application (2017-2022) & (K Units)
Table 141. Asia-Pacific Lisinopril Sales by Application (2023-2028) & (K Units)
Table 142. South America Lisinopril Sales by Country (2017-2022) & (K Units)
Table 143. South America Lisinopril Sales by Country (2023-2028) & (K Units)
Table 144. South America Lisinopril Revenue by Country (2017-2022) & (USD Million)
Table 145. South America Lisinopril Revenue by Country (2023-2028) & (USD Million)
Table 146. South America Lisinopril Sales by Type (2017-2022) & (K Units)
Table 147. South America Lisinopril Sales by Type (2023-2028) & (K Units)
Table 148. South America Lisinopril Sales by Application (2017-2022) & (K Units)
Table 149. South America Lisinopril Sales by Application (2023-2028) & (K Units)
Table 150. Middle East & Africa Lisinopril Sales by Region (2017-2022) & (K Units)
Table 151. Middle East & Africa Lisinopril Sales by Region (2023-2028) & (K Units)
Table 152. Middle East & Africa Lisinopril Revenue by Region (2017-2022) & (USD Million)
Table 153. Middle East & Africa Lisinopril Revenue by Region (2023-2028) & (USD Million)
Table 154. Middle East & Africa Lisinopril Sales by Type (2017-2022) & (K Units)
Table 155. Middle East & Africa Lisinopril Sales by Type (2023-2028) & (K Units)
Table 156. Middle East & Africa Lisinopril Sales by Application (2017-2022) & (K Units)
Table 157. Middle East & Africa Lisinopril Sales by Application (2023-2028) & (K Units)
Table 158. Lisinopril Raw Material
Table 159. Key Manufacturers of Lisinopril Raw Materials
Table 160. Direct Channel Pros & Cons
Table 161. Indirect Channel Pros & Cons
Table 162. Lisinopril Typical Distributors
Table 163. Lisinopril Typical Customers
List of Figures
Figure 1. Lisinopril Picture
Figure 2. Global Lisinopril Revenue Market Share by Type in 2021
Figure 3. 2.5mg
Figure 4. 5mg
Figure 5. 10mg
Figure 6. 20mg
Figure 7. 30mg
Figure 8. 40mg
Figure 9. Global Lisinopril Revenue Market Share by Application in 2021
Figure 10. Hospital
Figure 11. Drug Store
Figure 12. Global Lisinopril Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Lisinopril Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Lisinopril Sales (2017-2028) & (K Units)
Figure 15. Global Lisinopril Price (2017-2028) & (US$/Unit)
Figure 16. Global Lisinopril Production Capacity (2017-2028) & (K Units)
Figure 17. Global Lisinopril Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Lisinopril Market Drivers
Figure 19. Lisinopril Market Restraints
Figure 20. Lisinopril Market Trends
Figure 21. Global Lisinopril Sales Market Share by Manufacturer in 2021
Figure 22. Global Lisinopril Revenue Market Share by Manufacturer in 2021
Figure 23. Lisinopril Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Lisinopril Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Lisinopril Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Lisinopril Sales Market Share by Region (2017-2028)
Figure 27. Global Lisinopril Revenue Market Share by Region (2017-2028)
Figure 28. North America Lisinopril Revenue (2017-2028) & (USD Million)
Figure 29. Europe Lisinopril Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Lisinopril Revenue (2017-2028) & (USD Million)
Figure 31. South America Lisinopril Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Lisinopril Revenue (2017-2028) & (USD Million)
Figure 33. Global Lisinopril Sales Market Share by Type (2017-2028)
Figure 34. Global Lisinopril Revenue Market Share by Type (2017-2028)
Figure 35. Global Lisinopril Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Lisinopril Sales Market Share by Application (2017-2028)
Figure 37. Global Lisinopril Revenue Market Share by Application (2017-2028)
Figure 38. Global Lisinopril Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Lisinopril Sales Market Share by Type (2017-2028)
Figure 40. North America Lisinopril Sales Market Share by Application (2017-2028)
Figure 41. North America Lisinopril Sales Market Share by Country (2017-2028)
Figure 42. North America Lisinopril Revenue Market Share by Country (2017-2028)
Figure 43. United States Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Lisinopril Sales Market Share by Type (2017-2028)
Figure 47. Europe Lisinopril Sales Market Share by Application (2017-2028)
Figure 48. Europe Lisinopril Sales Market Share by Country (2017-2028)
Figure 49. Europe Lisinopril Revenue Market Share by Country (2017-2028)
Figure 50. Germany Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Lisinopril Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Lisinopril Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Lisinopril Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Lisinopril Revenue Market Share by Region (2017-2028)
Figure 59. China Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Lisinopril Sales Market Share by Type (2017-2028)
Figure 66. South America Lisinopril Sales Market Share by Application (2017-2028)
Figure 67. South America Lisinopril Sales Market Share by Country (2017-2028)
Figure 68. South America Lisinopril Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Lisinopril Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Lisinopril Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Lisinopril Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Lisinopril Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Lisinopril Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Lisinopril Revenue and Growth Rate (2017-2
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs